申请人:Ciba-Geigy Corporation
公开号:US04977181A1
公开(公告)日:1990-12-11
The present invention is concerned with the novel pharmaceutically acceptable tromethamine salt of 1-methyl-beta-oxo-alpha-(phenylcarbamoyl)-2-pyrrolepropionitrile of the formula II ##STR1## pharmaceutical compositions comprising said salt and a method of treating inflammatory and arthritic conditions in mammals by administering said salt to mammals in need of such treatment.
本发明涉及一种新型药用可接受的1-甲基-β-氧-α-(苯基氨甲酰)-2-吡咯丙腈的曲美他明盐,其化学式为II ##STR1## 包含该盐的制药组合物以及通过将该盐用于需要此类治疗的哺乳动物中来治疗炎症和关节炎的方法。